Offering effective personalized medicine for brain cancer patients
Find your care
Why choose UCLA Health for neuro-oncology care?
The UCLA Neuro-oncology Program is a leading comprehensive brain tumor program using molecular diagnostics, gene expression analysis, cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients. Our mission is to provide effective personalized medicine for brain cancer patients.
We've been providing consultations and primary medical oncology care to patients with primary brain and spinal cord tumors for over 25 years.
The patient evaluation and treatment approach takes advantage of our multidisciplinary collaboration with Neurosurgery, Neuroradiology, Neuropathology, and Radiation Oncology in the UCLA Brain Tumor Center to offer patients the most advanced imaging modalities, innovative and individualized chemotherapeutic protocols, and cutting edge molecularly-guided clinical trial treatments.
For additional information about the UCLA Neuro-oncology Program and UCLA Brain Tumor Center, please visit:
The Neuro-Oncology clinical team works together to provide you with the best possible and personalized care. The care team includes several attending physicians, nurse practitioners, Neuro-Oncology fellows, clinical social worker, and dedicated staff to meet the needs of all brain tumor patients.
- Melissa DePillo
- Daniel Gamboa
What to bring to your first visit:
- Insurance Card
- Medical records about current condition
- CD of DICOM compliant MR, CT, or PET scans
- Pathology Report
- Pathology Glass Slides
To schedule an appointment, please call:
At UCLA Neuro-Oncology Program, our sole focus is the care of brain tumor patients and the ability to push science and technology forward towards a cure. Donations we receive will allow us to move forward and help accelerate the application of personalized treatment. Your contribution will help better define treatments to improve the quality of life for individuals with brain tumors. To make a contribution please visit the following websites.